Drug intelligence / Profile preview

PeptiSleep

Development stage
Unknown
Lead developer
Nuritas
Modality
Peptides
Administration
Oral
01

Overview

PeptiSleep is a natural, plant-derived bioactive peptide ingredient developed by Nuritas using an AI-driven discovery platform[3][5][7][8]. It is sourced from rice bran protein and specifically designed to support all phases of sleep, enhancing both the quantity and quality of sleep—including deep and REM stages—without causing sedation or morning grogginess[3][5][7]. Mechanistically, PeptiSleep acts by modulating cortisol (helping to reduce stress-related hyperarousal) and downregulating the orexin (hypocretin) pathway, which calms the central nervous system and facilitates natural sleep onset and maintenance[1][8]. Clinically, PeptiSleep has demonstrated statistically significant improvements in measures such as sleep duration, sleep onset latency, sleep quality, and heart rate variability, supporting its role in promoting restorative sleep and balanced circadian rhythm[3][5][6][7]. It is a melatonin-free alternative, formulated for both dietary supplement and functional food applications, and can be found in numerous consumer products[4].

Brand names
PeptiSleep
Other names
PeptiSleep
02

Targets

HCRTR1 (Orexin/hypocretin receptor type 1)

Beyond the preview

Go deeper on PeptiSleep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PeptiSleep.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call